When to include clinical study reports and regulatory documents in systematic reviews
Reporting bias is a major threat to the validity and credibility of systematic reviews. This article outlines the rationale for accessing clinical study reports and other regulatory documents (regulatory data) as a means of addressing reporting bias and identifies factors that may help decide whethe...
| Päätekijät: | , , , , , , , , |
|---|---|
| Aineistotyyppi: | Journal article |
| Kieli: | English |
| Julkaistu: |
BMJ Publishing Group
2018
|
| _version_ | 1826265212289810432 |
|---|---|
| author | Jefferson, T Doshi, P Boutron, I Golder, S Heneghan, C Hodkinson, A Jones, M Lefebvre, C Stewart, L |
| author_facet | Jefferson, T Doshi, P Boutron, I Golder, S Heneghan, C Hodkinson, A Jones, M Lefebvre, C Stewart, L |
| author_sort | Jefferson, T |
| collection | OXFORD |
| description | Reporting bias is a major threat to the validity and credibility of systematic reviews. This article outlines the rationale for accessing clinical study reports and other regulatory documents (regulatory data) as a means of addressing reporting bias and identifies factors that may help decide whether (or not) to include regulatory data in systematic reviews. The article also describes the origins and current state of regulatory data access and summarises a survey of current systematic reviewers' practices in considering regulatory data for inclusion in systematic reviews. How to access and extract regulatory data is not addressed. Organisations and other stakeholders such as Cochrane should encourage the use of data from clinical study reports as an important source of data in reviews of pharmaceutical interventions particularly when the intervention in question is of high importance and the risk of reporting bias is great. |
| first_indexed | 2024-03-06T20:20:06Z |
| format | Journal article |
| id | oxford-uuid:2d814b49-65db-4e78-8df4-6ac551ee9753 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T20:20:06Z |
| publishDate | 2018 |
| publisher | BMJ Publishing Group |
| record_format | dspace |
| spelling | oxford-uuid:2d814b49-65db-4e78-8df4-6ac551ee97532022-03-26T12:43:25ZWhen to include clinical study reports and regulatory documents in systematic reviewsJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:2d814b49-65db-4e78-8df4-6ac551ee9753EnglishSymplectic Elements at OxfordBMJ Publishing Group2018Jefferson, TDoshi, PBoutron, IGolder, SHeneghan, CHodkinson, AJones, MLefebvre, CStewart, LReporting bias is a major threat to the validity and credibility of systematic reviews. This article outlines the rationale for accessing clinical study reports and other regulatory documents (regulatory data) as a means of addressing reporting bias and identifies factors that may help decide whether (or not) to include regulatory data in systematic reviews. The article also describes the origins and current state of regulatory data access and summarises a survey of current systematic reviewers' practices in considering regulatory data for inclusion in systematic reviews. How to access and extract regulatory data is not addressed. Organisations and other stakeholders such as Cochrane should encourage the use of data from clinical study reports as an important source of data in reviews of pharmaceutical interventions particularly when the intervention in question is of high importance and the risk of reporting bias is great. |
| spellingShingle | Jefferson, T Doshi, P Boutron, I Golder, S Heneghan, C Hodkinson, A Jones, M Lefebvre, C Stewart, L When to include clinical study reports and regulatory documents in systematic reviews |
| title | When to include clinical study reports and regulatory documents in systematic reviews |
| title_full | When to include clinical study reports and regulatory documents in systematic reviews |
| title_fullStr | When to include clinical study reports and regulatory documents in systematic reviews |
| title_full_unstemmed | When to include clinical study reports and regulatory documents in systematic reviews |
| title_short | When to include clinical study reports and regulatory documents in systematic reviews |
| title_sort | when to include clinical study reports and regulatory documents in systematic reviews |
| work_keys_str_mv | AT jeffersont whentoincludeclinicalstudyreportsandregulatorydocumentsinsystematicreviews AT doship whentoincludeclinicalstudyreportsandregulatorydocumentsinsystematicreviews AT boutroni whentoincludeclinicalstudyreportsandregulatorydocumentsinsystematicreviews AT golders whentoincludeclinicalstudyreportsandregulatorydocumentsinsystematicreviews AT heneghanc whentoincludeclinicalstudyreportsandregulatorydocumentsinsystematicreviews AT hodkinsona whentoincludeclinicalstudyreportsandregulatorydocumentsinsystematicreviews AT jonesm whentoincludeclinicalstudyreportsandregulatorydocumentsinsystematicreviews AT lefebvrec whentoincludeclinicalstudyreportsandregulatorydocumentsinsystematicreviews AT stewartl whentoincludeclinicalstudyreportsandregulatorydocumentsinsystematicreviews |